secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2022-06-24T23:59:59+00:00
Accession:  0001213900-22-034654
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics shareholders elect directors, ratify Marcum LLP as auditor
--------------------------------------------------------------------------------

- Elected five directors: Tiago Reis Marques, Yassine Bendiabdallah, Lawrence Steinman, Simon Dumesnil, Emer Leahy for one-year terms.
- Ratified appointment of Marcum LLP as independent auditor for FY 2022 with 10,751,385 votes for, 1,078,159 against.
- Annual Meeting held June 23, 2022; 22,858,371 shares outstanding as of record date May 3, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022034654/0001213900-22-034654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022034654/ea161983-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-034654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer